Ikumi Kuno

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis.

Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis.

Journal: Cancer medicine
Published: March 09, 2023

Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study.

Prevalence and characteristics of immune checkpoint inhibitor-related myocardial damage: A prospective observational study.

Journal: PloS one
Published: May 09, 2022

Urethral metastasis from esophageal cancer: symptoms of dysuria and cystoscopic diagnosis.

Urethral metastasis from esophageal cancer: symptoms of dysuria and cystoscopic diagnosis.

Journal: Oxford medical case reports
Published: April 26, 2022

Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer.

Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer.

Journal: Scientific reports
Published: March 18, 2022

Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma.

Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma.

Journal: Cancer science
Published: November 30, 2021

How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?

How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?

Journal: Journal of radiation research
Published: November 11, 2021

TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer.

TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer.

Journal: Scientific reports
Published: May 27, 2021

Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix.

Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix.

Journal: Cancers
Published: January 28, 2021

Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy.

Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy.

Journal: Scientific reports
Published: November 21, 2020

Chemotherapy-associated foam cell aggregates as a prognostic factor in patients with pelvic high-grade serous carcinoma receiving neo-adjuvant chemotherapy.

Chemotherapy-associated foam cell aggregates as a prognostic factor in patients with pelvic high-grade serous carcinoma receiving neo-adjuvant chemotherapy.

Journal: Virchows Archiv : an international journal of pathology
Published: December 25, 2019

Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.

Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.

Journal: Gynecologic oncology
Published: August 17, 2019

Characteristics and prognostic significance of incidentally detected cancer cells in uterine specimens of patients with pelvic high-grade serous carcinoma.

Characteristics and prognostic significance of incidentally detected cancer cells in uterine specimens of patients with pelvic high-grade serous carcinoma.

Journal: Cytopathology : official journal of the British Society for Clinical Cytology
Published: July 12, 2019
Showing 1-12 of 18

Last Updated: 09/26/2026